Nurix Therapeutics (NRIX) Research & Development (2019 - 2026)
Nurix Therapeutics (NRIX) posted Research & Development of $87.65 million for fiscal Q2 2026 (quarter ended May 31, 2026), up 12.2% from $78.1 million a year earlier and up 4.2% from the prior quarter.
Nurix Therapeutics (NRIX) Research & Development (2019 - 2026) Analysis & Trends
For the trailing twelve months through May 31, 2026, Research & Development at Nurix Therapeutics was $340.93 million, up 26.1% year-over-year; for FY2025 (ended Nov 30, 2025), it was $316.9 million, up 43.0% from FY2024.
- Annual Research & Development has increased for six consecutive fiscal years, with a five-year compound annual growth rate of 36.7% (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Research & Development was $221.63 million in FY2024 (+17.2%), $189.15 million in FY2023 (+2.5%), $184.5 million in FY2022 (+58.5%) and $116.43 million in FY2021 (+75.1%).
- The fiscal Q2 2026 figure stands as the highest quarterly Research & Development in data going back to fiscal Q3 2019.
- On a year-over-year basis, Research & Development has increased in each of the last 12 quarters, with growth averaging 32.7% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was fiscal Q1 2022, with growth of 87.5%; the weakest was fiscal Q2 2023, with a decline of 3.6%.
- According to Business Quant data, Research & Development for the three prior fiscal quarters was $84.14 million (Q1 2026), $83.02 million (Q4 2025) and $86.12 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | 87.65 Mn |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 87.65 Mn |
| Feb 28, 2026 | 84.14 Mn |
| Nov 30, 2025 | 83.02 Mn |
| Aug 31, 2025 | 86.12 Mn |
| May 31, 2025 | 78.10 Mn |
| Feb 28, 2025 | 69.66 Mn |
| Nov 30, 2024 | 67.22 Mn |
| Aug 31, 2024 | 55.48 Mn |
| May 31, 2024 | 48.92 Mn |
| Feb 29, 2024 | 50.01 Mn |
| Nov 30, 2023 | 49.71 Mn |
| Aug 31, 2023 | 47.86 Mn |
| May 31, 2023 | 45.76 Mn |
| Feb 28, 2023 | 45.82 Mn |
| Nov 30, 2022 | 46.11 Mn |
| Aug 31, 2022 | 47.76 Mn |
| May 31, 2022 | 47.49 Mn |
| Feb 28, 2022 | 43.14 Mn |
| Nov 30, 2021 | 36.53 Mn |
| Aug 31, 2021 | 30.91 Mn |
Nurix Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();